Most Targeted Cancer Drugs Lack Substantial Clinical BenefitApril 17, 2024Breast CancerGenitourinary CancerHead & Neck/Thyroid CancersLeukemia, Myelodysplasia, TransplantationLung CancerLymphoma & Plasma Cell DisordersMelanoma
No Routine Cancer Screening Option? New MCED Tests May HelpApril 15, 2024MelanomaLymphoma & Plasma Cell DisordersLung CancerLeukemia, Myelodysplasia, TransplantationHead & Neck/Thyroid CancersGenitourinary CancerBreast Cancer
Oncologists Voice Ethical Concerns Over AI in Cancer CareApril 12, 2024Breast CancerGenitourinary CancerHead & Neck/Thyroid CancersLeukemia, Myelodysplasia, TransplantationMelanomaLymphoma & Plasma Cell DisordersLung Cancer
Less Than 50% of Accelerated Approvals Show Clinical BenefitApril 9, 2024Breast CancerGenitourinary CancerHead & Neck/Thyroid CancersLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMelanomaMixed Topics
Virtual Reality Brings Relief to Hospitalized Patients With CancerApril 8, 2024OncologyBreast CancerGenitourinary CancerHead & Neck/Thyroid CancersLeukemia, Myelodysplasia, TransplantationLung CancerLymphoma & Plasma Cell Disorders
Should Opioids Be Used for Chronic Cancer Pain?April 5, 2024Breast CancerFast Facts FridayHead & Neck/Thyroid CancersLeukemia, Myelodysplasia, TransplantationLung CancerLymphoma & Plasma Cell DisordersMelanoma
A Banned Chemical That Is Still Causing CancerApril 3, 2024Breast CancerGenitourinary CancerHead & Neck/Thyroid CancersLeukemia, Myelodysplasia, TransplantationLung CancerLymphoma & Plasma Cell DisordersMelanoma
Active Surveillance for Cancer Doesn’t Increase Malpractice RiskApril 1, 2024Genitourinary CancerBreast CancerHead & Neck/Thyroid CancersLeukemia, Myelodysplasia, TransplantationLung CancerLymphoma & Plasma Cell DisordersMelanoma
Extraordinary Patients Inspired Father of Cancer ImmunotherapyMarch 19, 2024Mixed TopicsMelanomaLymphoma & Plasma Cell DisordersLung CancerLeukemia, Myelodysplasia, TransplantationHead & Neck/Thyroid CancersGenitourinary Cancer
Does worsening metabolic syndrome increase the risk of developing cancer?March 11, 2024Genitourinary CancerLeukemia, Myelodysplasia, TransplantationLung CancerLymphoma & Plasma Cell DisordersMelanomaMixed TopicsOncology
Dana-Farber Moves to Retract, Correct Dozens of Cancer Papers Amid AllegationsJanuary 25, 2024Genitourinary CancerBreast CancerLung CancerMelanomaLeukemia, Myelodysplasia, TransplantationHead & Neck/Thyroid Cancers
FDA’s Project Optimus aims to transform early cancer researchNovember 14, 2023AMLLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell Disorders
Does Gemcitabine Have a Curative Role in Treatment of Relapsed/Refractory Chronic Lymphocytic Leukemia?September 10, 2023Leukemia, Myelodysplasia, Transplantation
Asciminib Chronic Phase Chronic Myeloid Leukemia: A Real-World Single Institution Case SeriesSeptember 10, 2023Leukemia, Myelodysplasia, TransplantationOncology
Multiprong strategy makes clinical trials less WhiteJune 23, 2023Breast CancerGenitourinary CancerHead & Neck/Thyroid CancersLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMelanomaAML
